Desk› Healthcare› 3B BlackBio Dx Ltd

3B BlackBio Dx Ltd

BSE 532067 3BBLACKBIO INE994E01018

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Filing rhythm · 60 trading days

14 filings · 3 material · busiest 2026-06-25

What it files

Newspaper Publication3 General3 Analyst / Investor Meet2 Board Outcome1 Results1 Investor Presentation1 Board Meeting1 Trading Window1

Filings

14 in the window

25 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Analyst/ Investor Meet Intimation

Company Update / Analyst / Investor Meet View filing →
14 August 2026

Newspaper Publication

Newspaper Publication

Newspaper Publication of Unaudited Financial Results for the quarter ended 30th June, 2026

Company Update / Newspaper Publication View filing →
13 August 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting

Outcome of Board Meeting held on 13th August, 2026

Board Meeting / Outcome of Board Meeting View filing →
13 August 2026

Results

Unaudited Financial Results For The Quarter Ended 30Th June, 2026

Unaudited Financial Results for the quarter ended 30th June, 2026

Result / Financial Results View filing →
13 August 2026

Investor Presentation

Investor Presentation

Investor's Presentation

Company Update / Investor Presentation View filing →
5 August 2026

Board Meeting

Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The First Quarter Ended 30Th June, 2026.

3B Blackbio Dx Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....

Board Meeting / Board Meeting View filing →
9 July 2026

General

Intimation To The Holders Of Physical Securities To Furnish KYC Details

Intimation to the holders of physical securities to furnish KYC details

Company Update / General View filing →
6 July 2026

Newspaper Publication

Newspaper Publication

Special Window for Re-lodgement of Transfer Requests of physical shares

Company Update / Newspaper Publication View filing →
26 June 2026

Trading Window

Closure of Trading Window

Closure of Trading Window

Insider Trading / SAST / Closure of Trading Window View filing →
25 June 2026

General

Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations, 2011

Disclosure under Regulation 29 (2) of SEBI (SAST) Regulations, 2011

Company Update / General View filing →
25 June 2026

SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhirendra Dubey

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
25 June 2026

Newspaper Publication

Newspaper Publication

Newspaper Publication for Transfer of Unclaimed Dividend/Equity Shares to IEPF Authority

Company Update / Newspaper Publication View filing →
25 June 2026

General

Letter For Transfer Of Shares To Investor Education And Protection Fund (IEPF)

Specimen of letter sent to shareholders whose shares are liable to be transferred to IEPF

Company Update / General View filing →
3 June 2026

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter and Financial Year ended March 31, 2026

Company Update / Analyst / Investor Meet View filing →